Hamid Ferdosi

Hamid Ferdosi

Auto-generated profile, based on publicly available information

Hamid Ferdosi

Center for Epidemiology and Environmental Health (CEOH, LLC), Washington, DC 20016, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
SLSteven H. Lamm
Steven H. Lamm
HFHamid Ferdosi
Hamid Ferdosi
EDElisabeth K. Dissen
Elisabeth K. Dissen
JLJi Li
Ji Li
JAJaeil Ahn
Jaeil Ahn
High levels (> 200 µg/L) of inorganic arsenic in drinking water are known to be a cause of human lung cancer, but the evidence at lower levels is uncertain. We have sought the epidemiological studies that have examined the dose-response relationship between arsenic levels in drinking water and the risk of lung cancer over a range that includes both high and low levels of arsenic. Regression analysis, based on six studies identified from an electronic search, examined the relationship between the log of the relative risk and the log of the arsenic exposure over a range of 1–1000 µg/L. The best-fitting continuous meta-regression model was sought and found to be a no-constant linear-quadratic analysis where both the risk and the exposure had been logarithmically transformed. This yielded both a statistically significant positive coefficient for the quadratic term and a statistically significant negative coefficient for the linear term. Sub-analyses by study design yielded results that were similar for both ecological studies and non-ecological studies. Statistically significant X-intercepts consistently found no increased level of risk at approximately 100–150 µg/L arsenic.

1 May 2021 in Toxicology
Verified
Journal Article
Closed access
SLSteven H. Lamm
Steven H. Lamm
IBIsabella J. Boroje
Isabella J. Boroje
HFHamid Ferdosi
Hamid Ferdosi
JAJaeil Ahn
Jaeil Ahn

JAJaeil Ahn
Jaeil Ahn
IBIsabella J. Boroje
Isabella J. Boroje
HFHamid Ferdosi
Hamid Ferdosi
ZKZachary J. Kramer
Zachary J. Kramer
SLSteven H. Lamm
Steven H. Lamm
Background: Although inorganic arsenic in drinking water at high levels (100s–1000s μg/L [ppb]) increases cancer risk (skin, bladder, lung, and possibly prostate), the evidence at lower levels is limited. Methods: We conducted an ecologic analysis of the dose-response relationship between prostate cancer incidence and low arsenic levels in drinking water in a large study of U.S. counties (N = 710). County arsenic levels were <200 ug/L with median <100 ug/L and dependency greater than 10%. Groundwater well usage, water arsenic levels, prostate cancer incidence rates (2009–2013), and co-variate data were obtained from various U.S. governmental agencies. Poisson and negative-binomial regression analyses and stratified analysis were performed. Results: The best fitting polynomial analysis yielded a J-shaped linear-quadratic model. Linear and quadratic terms were significant (p < 0.001) in the Poisson model, and the quadratic term was significant (p < 0.05) in the negative binomial model. This model indicated a decreasing risk of prostate cancer with increasing arsenic level in the low range and increasing risk above. Conclusions: This study of prostate cancer incidence in US counties with low levels of arsenic in their well-water arsenic levels finds a j-shaped model with decreasing risk at very low levels and increasing risk at higher levels.

7 September 2018 in American Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
HFHamid Ferdosi
Hamid Ferdosi
KSKaren A Schwab
Karen A Schwab
AMAndrea Metti
Andrea Metti
LBLisa A Brenner
Lisa A Brenner
HTHeidi Terrio
Heidi Terrio
ASAnn I Scher
Ann I Scher
Postconcussive symptoms are believed to resolve in days or months in most instances for civilian injuries, though recent evidence suggests that recovery may be slower for injuries sustained during military deployment. The present study is based on a cohort of recently deployed soldiers from two US Army military bases (Fort Carson and Fort Bragg, followed from 2009-2015). Soldiers with and without a recent history of a deployment mild traumatic brain injury (mTBI) were evaluated within days of return and at 3, 6, and 12-months. Those with mTBI were more likely than non-mTBI to endorse one or more postconcussive symptoms at a severe and or very severe level (47% vs. 21% baseline; aRR=1.7 95% CI: 1.51,1.93 all-time points) and remained significant after adjusting for PTSD (aRR=1.34 95%CI: 1.41,1.82). Prevalence and relative risks (for three of most common baseline symptoms remained constant over time: sleep problems (RR=2.19), forgetfulness (RR=2.56), irritability (RR=2.73). The pattern was slightly different for headache, decreasing from RR=3.44 at baseline to RR=3.26 at 12 months, due to increased prevalence of headache in those without mTBI. . The prevalence of clinically relevant postconcussive symptoms remained relatively constant over one year of follow-up, whether or not symptoms were associated with concussion. Service members with recent mTBI reported more symptoms than non-mTBI at all time-points.

1 January 2016 in Journal of Environmental and Public Health
Verified
Journal Article
Open access
PDF file
HFHamid Ferdosi
Hamid Ferdosi
EDElisabeth K. Dissen
Elisabeth K. Dissen
NANana Ama Afari-Dwamena
Nana Ama Afari-Dwamena
JLJi Li
Ji Li
RCRusan Chen
Rusan Chen
SLSteven H. Lamm
Steven H. Lamm
Background.To examine whether the US EPA (2010) lung cancer risk estimate derived from the high arsenic exposures (10–934 µg/L) in southwest Taiwan accurately predicts the US experience from low arsenic exposures (3–59 µg/L).Methods. Analyses have been limited to US counties solely dependent on underground sources for their drinking water supply with median arsenic levels of ≥3 µg/L.Results. Cancer risks (slopes) were found to be indistinguishable from zero for males and females. The addition of arsenic level did not significantly increase the explanatory power of the models. Stratified, or categorical, analysis yielded relative risks that hover about 1.00. The unit risk estimates were nonpositive and not significantly different from zero, and the maximum (95% UCL) unit risk estimates for lung cancer were lower than those in US EPA (2010).Conclusions. These data do not demonstrate an increased risk of lung cancer associated with median drinking water arsenic levels in the range of 3–59 µg/L. The upper-bound estimates of the risks are lower than the risks predicted from the SW Taiwan data and do not support those predictions. These results are consistent with a recent metaregression that indicated no increased lung cancer risk for arsenic exposures below 100–150 µg/L.

SLSteven H. Lamm
Steven H. Lamm
IBIsabella J. Boroje
Isabella J. Boroje
HFHamid Ferdosi
Hamid Ferdosi
JAJaeil Ahn
Jaeil Ahn
While epidemiologic studies clearly demonstrate drinking water with high levels of arsenic as a significant risk factor for lung cancer, the evidence at low levels (≤50 μg/L) is uncertain. Therefore, we have conducted an ecological analysis of recent lung cancer incidence for US counties with a groundwater supply of <50 μg/L, the historical limit for both the EPA and WHO. Data sources used included USGS for arsenic exposure, NCI for lung cancer outcome, and CDC and US Census Bureau forcovariates. Poisson log-linear models were conducted for male, female, and total populations using for exposure median county arsenic level, maximum arsenic level ≤50 μg/L, and ≥80% population groundwater dependency. Statistically significant negative associations were found in each of the six models in which the exposure was limited to those who had major exposure (≥80% dependency) to low-levels of arsenic (≤50 μg/L). This is the first large ecological study of lung cancer risk from drinking water arsenic levels that specifically examined the dose-response slope for populations whose exposure was below the historical limit of ≤50 μg/L. The models for each of the three populations (total; male; female) demonstrated an association that is both negative and statistically significant.